Stay updated on Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial
Sign up to get notified when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.

Latest updates to the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a newer build of the page. This is a backend/version change rather than content-level updates.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded sections for How to Read a Study Record, Common Questions, and How to Join a Study, and displayed enrollment as No longer looking for participants, while updating the intervention labeling and revision tag from v3.5.5 to v3.6.0, reflecting an update to how the study details are presented and navigated.SummaryDifference0.4%

- Check24 days agoChange DetectedThe page footer's revision tag was updated to v3.5.5, replacing the previous v3.5.4; this reflects a software/patch update rather than a change to study information.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision label is updated to v3.5.4, indicating a minor update to the document version.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s footer revision/version was updated from **v3.5.2** to **v3.5.3**, indicating a site release rather than a change to the clinical trial study details.SummaryDifference0.1%

- Check74 days agoChange DetectedPage revision updated to v3.5.2; the previous revision was v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.